A Study Assessig The Correlation Between The Pharmacological Effect Of Tolvaptan And The Dynamics Of Urinary AQP2 Levels In Cirrhotic Patients With Massive Ascites Unresponsive To Standard Diuretic Therapy

Trial Profile

A Study Assessig The Correlation Between The Pharmacological Effect Of Tolvaptan And The Dynamics Of Urinary AQP2 Levels In Cirrhotic Patients With Massive Ascites Unresponsive To Standard Diuretic Therapy

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Mar 2017

At a glance

  • Drugs Tolvaptan (Primary)
  • Indications Ascites
  • Focus Pharmacodynamics
  • Most Recent Events

    • 17 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top